Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324136502> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4324136502 endingPage "318" @default.
- W4324136502 startingPage "318" @default.
- W4324136502 abstract "318 Background: Prostate cancer (PC) is the second most frequent malignancy in men worldwide. 68 Ga-PSMA-11 is one of the most widely used radiotracers for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with PC and is part of standard clinical practice at many centres. Due to the longer half-life and shorter positron range of copper-64 (t 1/2 =12.7 hours; mean positron range=0.56 mm), a novel PSMA-targeting radiotracer labelled with this radionuclide, 64 Cu-SAR-bisPSMA, has the potential to provide advantages over 68 Ga-PSMA-11 (t 1/2 =68 minutes; mean positron range=3.5 mm). The 12.7 hour half-life of Cu-64 allows the central manufacturing of 64 Cu-SAR-bisPSMA with a product shelf-life of up to 2 days. The longer half-life enables PET imaging from 1 to 72 hours after administration which offers greater flexibility in terms of scheduling of patients and may translate into detection of additional lesions due to increased Standardized Uptake Values (SUV) in the lesions relative to background following biological clearance of the tracer from organs over time. The shorter positron range may lead to improved resolution on the scan and thus, better detection of small lesions, including those that are in close proximity to each other, or to organs involved in clearance of the product such as the bladder and kidneys. In addition to the potential imaging and supply benefits of Cu-64, current generation PSMA targeting agents such as 68 Ga-PSMA-11 have only a single targeting functional group. 64 Cu-SAR-bisPSMA has two PSMA-targeting functional groups, which can lead to improved tumor uptake and retention. This was shown in a preclinical study, where 64 Cu-SAR-bisPSMA outperformed the monomeric 64 Cu-SAR-PSMA with respect to both tumor uptake and retention (Zia et al, 2019). Methods: Patients with untreated, histopathology-proven, intermediate- to high-risk PC, planned for radical prostatectomy underwent 68 Ga-PSMA-11 PET/CT per institutional practice and were subsequently allocated to 1 out of 3 dose cohorts (1:1:3) to receive either 100 MBq, 150 MBq or 200 MBq of 64 Cu-SAR-bisPSMA, respectively. A PET/CT was acquired at 3-hours (±1 hour) post-injection of 64 Cu-SAR-bisPSMA. Two independent, blinded, central readers assessed the detection of primary PC on the 200 MBq 64 Cu-SAR-bisPSMA PET/CTs as the primary endpoint. To compare the intensity of lesions on 68 Ga-PSMA-11 and 64 Cu-SAR-bisPSMA PET, both readers determined the SUVs (SUVmax, SUVmean) and tumour-to-background ratio (ratio of lesion SUVmax and background SUVmean) in up to 5 concordant lesions between 68 Ga-PSMA-11 and 64 Cu-SAR-bisPSMA PET/CT as an exploratory endpoint. Clinical trial information: NCT04839367 ." @default.
- W4324136502 created "2023-03-15" @default.
- W4324136502 creator A5021145923 @default.
- W4324136502 creator A5037689599 @default.
- W4324136502 creator A5057708677 @default.
- W4324136502 creator A5070907444 @default.
- W4324136502 creator A5087935247 @default.
- W4324136502 date "2023-02-20" @default.
- W4324136502 modified "2023-09-25" @default.
- W4324136502 title "Positron emission tomography of patients with confirmed prostate cancer using <sup>64</sup>Cu-SAR-bisPSMA." @default.
- W4324136502 doi "https://doi.org/10.1200/jco.2023.41.6_suppl.318" @default.
- W4324136502 hasPublicationYear "2023" @default.
- W4324136502 type Work @default.
- W4324136502 citedByCount "0" @default.
- W4324136502 crossrefType "journal-article" @default.
- W4324136502 hasAuthorship W4324136502A5021145923 @default.
- W4324136502 hasAuthorship W4324136502A5037689599 @default.
- W4324136502 hasAuthorship W4324136502A5057708677 @default.
- W4324136502 hasAuthorship W4324136502A5070907444 @default.
- W4324136502 hasAuthorship W4324136502A5087935247 @default.
- W4324136502 hasConcept C121332964 @default.
- W4324136502 hasConcept C121608353 @default.
- W4324136502 hasConcept C126322002 @default.
- W4324136502 hasConcept C147120987 @default.
- W4324136502 hasConcept C202100949 @default.
- W4324136502 hasConcept C20417620 @default.
- W4324136502 hasConcept C2775842073 @default.
- W4324136502 hasConcept C2776235491 @default.
- W4324136502 hasConcept C2779399171 @default.
- W4324136502 hasConcept C2780192828 @default.
- W4324136502 hasConcept C2908761598 @default.
- W4324136502 hasConcept C2989005 @default.
- W4324136502 hasConcept C37097830 @default.
- W4324136502 hasConcept C62520636 @default.
- W4324136502 hasConcept C71924100 @default.
- W4324136502 hasConceptScore W4324136502C121332964 @default.
- W4324136502 hasConceptScore W4324136502C121608353 @default.
- W4324136502 hasConceptScore W4324136502C126322002 @default.
- W4324136502 hasConceptScore W4324136502C147120987 @default.
- W4324136502 hasConceptScore W4324136502C202100949 @default.
- W4324136502 hasConceptScore W4324136502C20417620 @default.
- W4324136502 hasConceptScore W4324136502C2775842073 @default.
- W4324136502 hasConceptScore W4324136502C2776235491 @default.
- W4324136502 hasConceptScore W4324136502C2779399171 @default.
- W4324136502 hasConceptScore W4324136502C2780192828 @default.
- W4324136502 hasConceptScore W4324136502C2908761598 @default.
- W4324136502 hasConceptScore W4324136502C2989005 @default.
- W4324136502 hasConceptScore W4324136502C37097830 @default.
- W4324136502 hasConceptScore W4324136502C62520636 @default.
- W4324136502 hasConceptScore W4324136502C71924100 @default.
- W4324136502 hasIssue "6_suppl" @default.
- W4324136502 hasLocation W43241365021 @default.
- W4324136502 hasOpenAccess W4324136502 @default.
- W4324136502 hasPrimaryLocation W43241365021 @default.
- W4324136502 hasRelatedWork W1963655545 @default.
- W4324136502 hasRelatedWork W2056929691 @default.
- W4324136502 hasRelatedWork W2238158061 @default.
- W4324136502 hasRelatedWork W2332906197 @default.
- W4324136502 hasRelatedWork W2597961668 @default.
- W4324136502 hasRelatedWork W2736007806 @default.
- W4324136502 hasRelatedWork W2976224709 @default.
- W4324136502 hasRelatedWork W3094608289 @default.
- W4324136502 hasRelatedWork W4285011787 @default.
- W4324136502 hasRelatedWork W4324136502 @default.
- W4324136502 hasVolume "41" @default.
- W4324136502 isParatext "false" @default.
- W4324136502 isRetracted "false" @default.
- W4324136502 workType "article" @default.